Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (10479)	6/16/1999 1:04:00 AM
From: aknahow	Respond to of 17367

Would they call it Aeroprex? Aeroprex? I like the sound of that. Think I heard it once before. At any rate XOMA has it trade marked. I asked XOMA to tell us all about Aeroprex but that was months ago. Not a big deal but something of interest, worth at least a 1,000 post. <g>

To: Cacaito who wrote (10479)	6/16/1999 5:08:00 PM
From: aknahow	Read Replies (2) \| Respond to of 17367

Cacaito, a link to article on AARDS which might have some value if and when we receive something from XOMA regarding the trauma trial. wwilkins.com Any possibility that XOMA has already concluded this trial? The fact that they are holding back on accrual data and that the meager and vague information provided over a month ago does not appear to change. Makes me wonder what is going on. If they were continuing to add 70 per month the number would have changed. They should be around 1,000 at the start of June. Of course one could say there is not much difference between 890 and 1,000.